TMEM52B and renal cell carcinoma: In contrast to our finding, Xie reported the loss of C12orf59 expression is a common feature of Renal cell carcinoma that is correlated with increased aggressive tumor behavior and predicts poor survival outcomes of patients, suggesting a potential tumor-suppresive role of C12orf59 in this disease [10].